InnoGrant Advisors

InnoGrant Advisors is an innovation and funding advisory firm helping biotech companies and cross-industry technology providers launch and scale collaborative projects with international partners. We work at the interface of science, strategy, and finance—supporting teams to (1) sharpen the value proposition and clinical/market relevance, (2) design robust workplans and consortia, and (3) secure public and blended financing (Eureka network instruments, Horizon Europe, Innosuisse and complementary regional/national programs).
We are particularly interested in collaborations connecting diagnostics, lab automation, digital health, therapeutics/medtech combination products, and industrial biotech with enabling capabilities such as digitalisation, translational research, chemistry, manufacturing scale-up, and CMC/QC. If you are building an international project and need the right partners, a compelling funding narrative, or a route to measurable market pull, we would welcome a conversation at GIS 2026.

Matchmaking add-on (highly effective on event platforms)

What we offer:

• Partner sourcing and consortium design for international collaborative projects

• Investability and funding workshops

• Funding readiness

• Funding strategy and proposal architecture (Eureka/Horizon/Innosuisse alignment)

• Commercialization planning: market pull, pricing/reimbursement logic, stakeholder mapping GTM Strategy

• Scale-up readiness

• Board roles

• Fractional CXO / Entrepreneur in Residence

• Innovation Mentoring

• What we are looking for:

• Biotech SMEs, scale-ups, and technology providers seeking international project partners and funding (public or private)

• Large industrial partners ready to scale innovation

• Diagnostics/lab automation/digital health innovators with clear clinical or operational use cases

• Manufacturing/CMC/QC, CDMO, data/AI, and digitalisation partners enabling translation and scale

• Academic/RTO groups ready to engage in industry-driven, impact-oriented consortia